Paper Details

  1. Home
  2. Paper Details

Improving chemotherapy for patients with advanced non-small cell lung cancer.

Author: von PlessenChristian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Lung cancer is a major cause of death in developed countries. Most patients with advanced, non-small cell lung cancer (NSCLC) cannot be cured and receive chemotherapy to manage symptoms. While chemotherapy can extend life and improve quality of life, it also has side effects, and few patients fully respond. There is a need for research to determine the best duration of chemotherapy treatment. Improving the environment and processes of delivering chemotherapy can enhance patient and staff satisfaction and improve overall care, especially for patients with limited time. Research on the effectiveness of chemotherapy in different populations, including older adults and those with better general health, is also important.
Paper Details　
Original Abstract of the Article :
Lung cancer is the third most common mortal disease in industrialised countries and the prognosis has been slow to improve. The largest subgroup has locally advanced or metastatic non-small cell lung cancer (NSCLC). Unfortunately, these patients can usually not be cured and the main treatment option...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1752-699X.2010.00199.x

データ提供：米国国立医学図書館（NLM）

Optimizing Chemotherapy for Advanced Non-Small Cell Lung Cancer

Navigating the complexities of [advanced non-small cell lung cancer (NSCLC)] is a challenging journey for both patients and healthcare providers. This study delves into the crucial topic of [palliative chemotherapy] for advanced NSCLC, exploring strategies to improve treatment efficacy and enhance patient well-being. The authors address the need for optimizing treatment duration, considering the balance between extending survival and improving quality of life. The study also emphasizes the importance of improving the delivery of chemotherapy, acknowledging the impact of supportive care on patient satisfaction and overall treatment experience. This research provides valuable insights for guiding clinical practice and ensuring optimal care for individuals facing this challenging disease.

Improving the Quality of Life for NSCLC Patients

This research sheds light on the critical need for optimizing [palliative chemotherapy] for [advanced NSCLC] patients. The authors emphasize the importance of establishing optimal treatment duration, balancing the benefits of extended survival with the desire for improved quality of life. The study highlights the need for controlled clinical trials to provide guidance on treatment duration, ensuring that patients receive the most appropriate care. Furthermore, the study emphasizes the importance of improving the delivery of chemotherapy, recognizing that a supportive and patient-centered approach can enhance patient satisfaction and overall treatment experience.

Navigating the Complexities of Advanced Lung Cancer

Managing [advanced NSCLC] requires a multifaceted approach that encompasses both treatment and supportive care. This study underscores the importance of optimizing chemotherapy regimens and treatment durations while simultaneously addressing the emotional and practical needs of patients. It highlights the need for continued research and collaborative efforts to improve the quality of life for individuals facing this challenging disease. By striving to enhance both survival and well-being, we can provide more compassionate and effective care for patients with advanced NSCLC.

Dr.Camel's Conclusion

Just as a camel adapts to the arid desert environment, individuals with advanced NSCLC require a resilient approach to managing their disease. This study reminds us that optimizing chemotherapy regimens and treatment duration is crucial for extending survival and improving quality of life. Remember, compassionate care and a supportive environment are essential for navigating this challenging journey. By working together, patients, families, and healthcare providers can create a more hopeful and empowering experience for those facing advanced NSCLC.

Date :
  1. Date Completed 2011-04-20
  2. Date Revised 2010-12-16
Further Info :

Pubmed ID

21159143

DOI: Digital Object Identifier

10.1111/j.1752-699X.2010.00199.x

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.